tradingkey.logo
tradingkey.logo
Search

Telix Pharmaceuticals Ltd

TLX
Add to Watchlist
11.870USD
+0.030+0.25%
Close 07/02, 13:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Telix Pharmaceuticals Ltd

11.870
+0.030+0.25%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+0.25%

5 Days

+11.35%

1 Month

+24.42%

6 Months

+55.77%

Year to Date

+58.48%

1 Year

-26.14%

Key Figures
12.090Open
12.175High
255.24KVolume
--P/E TTM
0.00P/E Dynamic
--Dividend TTM
--Turnover Ratio
11.840Prev. Close
11.730Low
2.20MTurnover
--P/E Static
--P/B
0.00%Div Yield TTM
--ROA
18.49052wk High
2.07Volume Ratio
--Net Profit
--Shares
--EPS TTM
--Beta
--ROE
6.28052wk Low
3.76%Amplitude
--Gross Margin
0.00Market Cap
13.44Reward/Risk
1.79%Risk Rate

TradingKey Stock Score

No stock score available due to insufficient data.

Telix Pharmaceuticals Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Telix Pharmaceuticals Ltd Info

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Ticker SymbolTLX
CompanyTelix Pharmaceuticals Ltd
CEOOrtiz (Raphaeel)
Websitehttps://telixpharma.com/

FAQs

What is the current price of Telix Pharmaceuticals Ltd (TLX)?

The current price of Telix Pharmaceuticals Ltd (TLX) is 11.87.

What is the symbol of Telix Pharmaceuticals Ltd?

The ticker symbol of Telix Pharmaceuticals Ltd is TLX.

What is the 52-week high of Telix Pharmaceuticals Ltd?

The 52-week high of Telix Pharmaceuticals Ltd is 18.49.

What is the 52-week low of Telix Pharmaceuticals Ltd?

The 52-week low of Telix Pharmaceuticals Ltd is 6.28.

Is Telix Pharmaceuticals Ltd (TLX) currently rated as Buy, Hold, or Sell?

According to analysts, Telix Pharmaceuticals Ltd (TLX) has an overall rating of STRONG BUY, with a price target of 19.42.